Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DCZ28G
|
|||
| Drug Name |
Ibezapolstat
|
|||
| Synonyms |
ACX-362E; UNII-5K543KNC5P; 5K543KNC5P; Ibezapolstat (USAN); Ibezapolstat [USAN]; 1275582-97-2; ACX362E; CHEMBL4571518; SCHEMBL15908884; GTPL11030; WHO 11365; HY-128357; CS-0099071; D11791; 2-[(3,4-dichlorophenyl)methylamino]-7-(2-morpholin-4-ylethyl)-1H-purin-6-one; 2-[(3,4-dichlorophenyl)methylamino]-7-(2-morpholin-4-ylethyl)-3H-purin-6-one; 2-(((3,4-Dichlorophenyl)methyl)amino)-1,7-dihydro-7-(2-(4-morpholinyl)ethyl)-6H-purin-6-one; 6H-Purin-6-one, 2-(((3,4-dichlorophenyl)methyl)amino)-1,7-dihydro-7-(2-(4-morpholinyl)ethyl)-
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Clostridium infection [ICD-11: 1A04; ICD-10: A04.7] | Phase 2 | [1] | |
| Company |
Acurx Pharmaceuticals
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C18H20Cl2N6O2
|
|||
| Canonical SMILES |
C1COCCN1CCN2C=NC3=C2C(=O)NC(=N3)NCC4=CC(=C(C=C4)Cl)Cl
|
|||
| InChI |
1S/C18H20Cl2N6O2/c19-13-2-1-12(9-14(13)20)10-21-18-23-16-15(17(27)24-18)26(11-22-16)4-3-25-5-7-28-8-6-25/h1-2,9,11H,3-8,10H2,(H2,21,23,24,27)
|
|||
| InChIKey |
DEGSGBKTODESHH-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 1275582-97-2
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04247542) ACX-362E [Ibezapolstat] for Oral Treatment of Clostridioides Difficile Infection. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.